France / Français
With Input from MHAC, ‘Connecting Communities through Digital Equity' Report Released by MassINC, MACP
1 month ago - By Massachusetts Healthy Aging Collaborative
The Massachusetts Healthy Aging Collaborative is grateful to have participated in a working group led by MassINC and the Massachusetts Competitive Partnership that informed a new report titled “ Connecting Communities Through Digital Equity .”
The report builds on MassINC's 2020 digital divide research , framing the challenges and opportunities ahead, and outlining a near-term action plan.
MHAC was able to promote inclusion of older adults within the report, which advocates for a cross-sector and collaborative approach to advancing digital equity. There are also case study examples from...
Read more ...
Search by Tags
Plan Data and Reports Access Equity Inclusion Digital divide Digital equity
The headlines of Master Doctor
Researchers crack the code to muscle generation
In a new study, researchers from the University of Copenhagen have identified a protein that the body...
Early natural menopause increases risk for lung diseases, death in women who...
In midlife and older smokers, natural menopause before age 45 years was associated with malignant and nonmalignant lung diseases and mortality, according to data published in...
Disrupted nights during menopause cost women FIVE WEEKS' sleep every year...
Women lose five and a half weeks of sleep a year due to the menopause, a study has suggested. These women wake up on average 2.7 times a night and experience a variety of issues.
Episode 445 - Full Transcript
From podcast Podcast Sponsors Ginger for Healthy Ageing Antiaging
Therapeutic target for several metabolic diseases may help fight Alzheimer's...
In the recent popular Korean TV series "The Light in Your Eyes," many viewers emphasized with the main character suffering from Alzheimer's disease.
Lose Weight, Slow Knee OA Progression? New Study Suggests Yes
Declines in body mass index were linked with slower worsening of knee osteoarthritis , according to data from three large longitudinal cohort studies. With more than 6,000...
FDA accepts new drug application for fezolinetant
The FDA accepted a new drug application from Astellas for fezolinetant, a nonhormonal drug for treating moderate to severe menopause-related vasomotor symptoms, according to a...
Q&A 445: The Best New Anti-Aging Compounds, Gut Healing Supplements, What...
Have a question you'd like Ben to answer on the podcast?
Inflation Reduction Act Cuts Prescription Drug Costs for Older Adults
With the Inflation Reduction Act of 2022 signed into law on Aug. 16, millions of Medicare enrollees will be able to better afford their life-sustaining medications, and...
Denosumab biosimilar displays noninferiority in postmenopausal patients with...
A denosumab biosimilar candidate demonstrated noninferior efficacy to its reference product, with similar safety profile, in postmenopausal patients with osteoporosis...